Evidence map›Paper›PMID 42038391›Full record

ArticleFrontiers in oncology2026

A novel combined model integrating collagen properties, radiomics and clinical data to predict gastric cancer prognosis.

Yequan Xie, Guangyu Zhong, Jintao Zeng, Zhenqi Meng, Shilin Zhi, Yang Chen, Fanghai Han, Jianan Tan, Shengning Zhou

Abstract read
In one paragraph

Article in Frontiers in oncology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Yequan XieDepartment of Gastrointestinal Surgery, The Affiliated Guangdong Second Provincial General Hospital of Jinan University, Guangzhou, Guangdong, China.
Guangyu ZhongDepartment of Gastrointestinal Surgery, The Affiliated Guangdong Second Provincial General Hospital of Jinan University, Guangzhou, Guangdong, China.
Jintao ZengDepartment of Gastrointestinal Surgery, The Affiliated Guangdong Second Provincial General Hospital of Jinan University, Guangzhou, Guangdong, China.
Zhenqi MengDepartment of Gastrointestinal Surgery, The Affiliated Guangdong Second Provincial General Hospital of Jinan University, Guangzhou, Guangdong, China.
Shilin ZhiDepartment of Gastrointestinal Surgery, The Affiliated Guangdong Second Provincial General Hospital of Jinan University, Guangzhou, Guangdong, China.
Yang ChenDepartment of Gastrointestinal Surgery, The Affiliated Guangdong Second Provincial General Hospital of Jinan University, Guangzhou, Guangdong, China.
Fanghai HanDepartment of Gastrointestinal Surgery, The Affiliated Guangdong Second Provincial General Hospital of Jinan University, Guangzhou, Guangdong, China.
Jianan TanDepartment of Gastrointestinal Surgery, The Affiliated Guangdong Second Provincial General Hospital of Jinan University, Guangzhou, Guangdong, China.
Shengning ZhouDepartment of Gastrointestinal Surgery, The Affiliated Guangdong Second Provincial General Hospital of Jinan University, Guangzhou, Guangdong, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Introduction: Gastric cancer (GC) is one of the most common malignant tumors in the world, and there is still no good method to predict the prognosis of GC patients. Collagens are the major component of the extracellular matrix (ECM), and abnormalities in collagen are closely associated with the development of GC. Methods: This study investigated collagen signatures in GC using bioinformatics analysis and picrosirius red staining. A total of 196 GC patients were included, with 138 assigned to the training group and 58 to the validation group. Multivariate analysis was performed to evaluate prognostic factors, and a predictive model was constructed by integrating collagen properties, radiomics, and clinical data. Results: The study revealed that collagen signatures were associated with GC initiation and progression. Multivariate analysis confirmed that the picrosirius red risk score (HR = 1.1, 95% CI: 1.02-1.18, p = 0.013) and Radscore (HR = 2.34, 95% CI: 1.3-4.21, p = 0.005) were independent prognostic factors for overall survival. The combined model demonstrated high accuracy, with a C-index of 0.9 in the training group and 0.84 in the validation group, along with good goodness of fit and net benefit. Discussion: These findings suggest that a prognostic model integrating multiple types of data, including collagen characteristics, radiomics, and clinical factors, can better predict the overall survival of GC patients.

Indexed as

collagen remodelingCT imaginggastric cancerprognostic modelradiomics

Identifiers

PMID42038391
PMCPMC13105883

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.